BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 24580813)

  • 21. Impact along the HIV pre-exposure prophylaxis "cascade of prevention" in western Kenya: a mathematical modelling study.
    Bershteyn A; Sharma M; Akullian AN; Peebles K; Sarkar S; Braithwaite RS; Mudimu E
    J Int AIDS Soc; 2020 Jun; 23 Suppl 3(Suppl 3):e25527. PubMed ID: 32602669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.
    Haberer JE
    Curr Opin HIV AIDS; 2016 Jan; 11(1):10-7. PubMed ID: 26633638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interventions to improve daily medication use among adolescents and young adults: what can we learn for youth pre-exposure prophylaxis services?
    Velloza J; Kapogiannis B; Bekker LG; Celum C; Hosek S; Delany-Moretlwe S; Baggaley R; Dalal S
    AIDS; 2021 Mar; 35(3):463-475. PubMed ID: 33252486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What primary care providers need to know about preexposure prophylaxis for HIV prevention: a narrative review.
    Krakower D; Mayer KH
    Ann Intern Med; 2012 Oct; 157(7):490-7. PubMed ID: 22821365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies.
    Gomez GB; Borquez A; Case KK; Wheelock A; Vassall A; Hankins C
    PLoS Med; 2013; 10(3):e1001401. PubMed ID: 23554579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Real-time monitoring and just-in-time intervention for adherence to pre-exposure prophylaxis among men who have sex with men in China: a multicentre RCT study protocol.
    Jin X; Wang H; Li H; Chu Z; Zhang J; Hu Q; Lv W; Huang X; Chen Y; Wang H; He X; Zhang L; Hu Z; Bao R; Li S; Ding H; Geng W; Jiang Y; Shang H; Xu J;
    BMC Public Health; 2020 Jul; 20(1):1160. PubMed ID: 32709230
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing content for pre-exposure prophylaxis (PrEP) counseling for men who have sex with men: Perspectives of PrEP users and high-risk PrEP naïve men.
    Wade Taylor S; Mayer KH; Elsesser SM; Mimiaga MJ; O'Cleirigh C; Safren SA
    AIDS Behav; 2014 May; 18(5):871-9. PubMed ID: 24077928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing determinants of pre-exposure prophylaxis (PrEP) adherence among a sample of rural Midwestern men who have sex with men (MSM).
    Owens C; Hubach RD; Lester JN; Williams D; Voorheis E; Reece M; Dodge B
    AIDS Care; 2020 Dec; 32(12):1581-1588. PubMed ID: 32338061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Review of Pre-Exposure Prophylaxis Adherence among Female Sex Workers.
    Ghayda RA; Hong SH; Yang JW; Jeong GH; Lee KH; Kronbichler A; Solmi M; Stubbs B; Koyanagi A; Jacob L; Oh H; Kim JY; Shin JI; Smith L
    Yonsei Med J; 2020 May; 61(5):349-358. PubMed ID: 32390358
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systemic and topical drugs for the prevention of HIV infection: antiretroviral pre-exposure prophylaxis.
    Baeten J; Celum C
    Annu Rev Med; 2013; 64():219-32. PubMed ID: 23020883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.
    Shrestha R; Altice FL; Sibilio B; Ssenyonjo J; Copenhaver MM
    Contemp Clin Trials; 2019 Jul; 82():77-84. PubMed ID: 31229618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to pre-exposure prophylaxis among men who have sex with men: A prospective cohort study.
    Qu D; Zhong X; Xiao G; Dai J; Liang H; Huang A
    Int J Infect Dis; 2018 Oct; 75():52-59. PubMed ID: 30125688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experienced barriers to adherence to pre-exposure prophylaxis for HIV prevention among MSM: a systematic review and meta-ethnography of qualitative studies.
    Edeza A; Karina Santamaria E; Valente PK; Gomez A; Ogunbajo A; Biello K
    AIDS Care; 2021 Jun; 33(6):697-705. PubMed ID: 32530302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How Can Programs Better Support Female Sex Workers to Avoid HIV Infection in Zimbabwe? A Prevention Cascade Analysis.
    Fearon E; Phillips A; Mtetwa S; Chabata ST; Mushati P; Cambiano V; Busza J; Napierala S; Hensen B; Baral S; Weir SS; Rice B; Cowan FM; Hargreaves JR
    J Acquir Immune Defic Syndr; 2019 May; 81(1):24-35. PubMed ID: 30964804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study on Pre-Exposure Prophylaxis Regimens among Men Who Have Sex with Men: A Prospective Cohort Study.
    Wu D; Tao H; Dai J; Liang H; Huang A; Zhong X
    Int J Environ Res Public Health; 2019 Dec; 16(24):. PubMed ID: 31818006
    [No Abstract]   [Full Text] [Related]  

  • 36. The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study.
    Gomez GB; Borquez A; Caceres CF; Segura ER; Grant RM; Garnett GP; Hallett TB
    PLoS Med; 2012; 9(10):e1001323. PubMed ID: 23055836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preexposure prophylaxis for the prevention of HIV transmission to women.
    Aaron E; Cohan D
    AIDS; 2013 Jan; 27(1):F1-5. PubMed ID: 22914582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study.
    Mboup A; Béhanzin L; Guédou FA; Geraldo N; Goma-Matsétsé E; Giguère K; Aza-Gnandji M; Kessou L; Diallo M; Kêkê RK; Bachabi M; Dramane K; Geidelberg L; Cianci F; Lafrance C; Affolabi D; Diabaté S; Gagnon MP; Zannou DM; Gangbo F; Boily MC; Vickerman P; Alary M
    J Int AIDS Soc; 2018 Nov; 21(11):e25208. PubMed ID: 31291057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV providers' likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: a short report.
    Adams LM; Balderson BH
    AIDS Care; 2016 Sep; 28(9):1154-8. PubMed ID: 26915281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study design considerations for evaluating efficacy of systemic preexposure prophylaxis interventions.
    Donnell D; Hughes JP; Wang L; Chen YQ; Fleming TR
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2(0 2):S130-4. PubMed ID: 23764624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.